HSE warns pharma firms about payments to doctors

The Health Service Executive (HSE) has warned that it may stop buying medicines from pharmaceutical companies who do not name the individual doctors and healthcare organisations in receipt of multimillion euro payments from them.

The HSE wants pharmaceutical companies to name those in receipt of payments for travel, sponsorship, medical education, grants, medical and nursing posts, and various other unknown activities.

Last November, this newspaper revealed that hospitals were unable to account for ...